HEALTH WATCH: New Drugs Could Help Alzheimer's
Posted on: Wednesday, 21 December 2005, 12:00 CST
THE relentless rise in the population of the degenerative brain disease Alzheimer's could be halted by a new generation of drugs which are being developed for a different condition altogether.
Researchers at the University of Ulster have found that drugs being developed to combat diabetes could also prevent nerve degeneration caused by Alzheimer's disease.
Neurobiologist Dr Christian Holscher, who heads the Alzheimer Research Group at the university's Coleraine campus, has teamed up with the university's internationally-renowned diabetes research group to investigate links between the two diseases.
Recent research has shown a surprising link between Alzheimer's and diabetes, two of the major health challenges facing society today. According to Dr Holscher, modern lifestyle promotes the development of type 2 diabetes, which in turn could drastically increase the number of people who develop Alzheimer's disease, as people with type 2 diabetes are much more likely to develop the disease than healthy people of the same age.
"Overeating, high fat and sugar content in the diet, combined with little physical activity all increase the chances of a person developing type 2 diabetes," he says. "The number of people with this form of diabetes has rocketed in the last 10 years.
"Type 2 diabetes used to be called 'old age diabetes', but now even children as young as 10 years old develop it. In the next decade, it is estimated that the number of obese people will double and that one in five will be considered obese or heavily overweight."
He explains: "Blood sugar levels are high in type 2 diabetes patients because the cells do not respond to insulin any more. Insulin is the hormone that controls the levels of blood sugar and stimulates cell growth and repair.
"Alzheimer's causes the brain to slowly degenerate. In the brains of patients with Alzheimer's, proteins called beta-amyloid and tau accumulate and start to aggregate to lumps called plaques and tangles. Though all people have this protein, it appears to aggregate at alarming rates in some people and this can kill neurons over time."
Recent research has shown that developing type 2 diabetes makes neurons in the brain more vulnerable to attack and to damaging influences. Protective mechanisms in the brain lose their effectiveness in protecting neurons and promoting growth and repair.
UU researchers are now investigating whether the drugs being developed to combat diabetes could also benefit the defence mechanisms of the brain against the neurodegeneration that develops in people suffering from Alzheimer's disease.
Standard drugs given to diabetic patients do not enter the brain, so the research team at UU has developed new techniques to test novel drugs on brain activity. Dr Holscher says he is very encouraged by recent research results.
"We have found that novel diabetes drugs not only improve type 2 diabetes, but that they also have a powerful effect on neurons to help fight off the damaging effects of beta-amyloid proteins and plaques. This research could pave the way to developing new drugs that are specific for the protection of the brain of diabetic people."
Source: Belfast News Letter, The
Related Articles
- Alzheimer's Drug Discovery Foundation Funds Abiant, Inc. to Develop a Positron Emission Tomography (PET) Imaging Diagnostic for Alzheimer's Disease
- Phase 3 Alzheimer's Drug Increases Toxic Beta Amyloid In The Brain Cut Can Still Provides Benefits
- A Phase III Alzheimer's Drug Increases Levels of Beta Amyloid in the Brain - But Still Provides Benefits
- Cellumen Partners With Alzheimer's Drug Discovery Foundation to Develop New Assays for Early Treatment of Alzheimer's
- New Alzheimer’s Drug Shows Success In Halting Disease Progression
- Alzheimer's Drug Discovery Foundation Hosts Second Annual Connoisseur's Dinner
- Alzheimer's Drug Discovery Foundation Funds PharmatrophiX to Develop Drugs to Prevent Neurodegenerative Disease
- Eisai Forms Alliance With Swedish Firm for Alzheimer Drug Research
- Discovery Could Lead to New Types of Alzheimer's Drugs
- Drug Companies Research Rare Diseases in North Carolina
User Comments (0)

RSS Feeds